Cantor

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Cantor

Quick Facts

Property Description
Active ingredient Piroxicam
Form Oral Capsule, Tablet, Topical Gel
Pharmacological class Nonsteroidal Anti-inflammatory Drug (NSAID)
Common use Relief of pain and inflammation
Origin Synthetic

What Type of Medicine is Cantor (Piroxicam)?

Cantor is a Nonsteroidal Anti-inflammatory Drug (NSAID) whose active substance is Piroxicam. The drug is a synthetic, single-ingredient compound classified within the oxicam chemical sub-class, which comprises potent enolic acid derivatives. Piroxicam is recognized globally as an established NSAID, and its structure is characterized by a significantly long half-life when compared to shorter-acting compounds.

The classification of Piroxicam as an NSAID confirms that the medicine is fundamentally designed to reduce symptoms caused by inflammation. The oxicam family of drugs provides relief from chronic inflammatory discomfort. This means the medicine is clinically recognized for managing discomfort and swelling.


What is the General Purpose of Cantor?

The primary purpose of Cantor is to provide anti-inflammatory activity and effective analgesic (pain-relieving) properties. It achieves this by broadly modulating the body's response to irritation and tissue changes. Piroxicam works by inhibiting the action of cyclooxygenase (COX) enzymes, thereby reducing the body's synthesis of prostaglandins, which are the fundamental chemical messengers responsible for causing pain, stiffness, and swelling. For example, it is typically used for the general relief of stiffness and pain commonly associated with conditions like arthritis.


What Forms Does Cantor Come In?

Cantor is available in several dosage forms that allow for different routes of administration, including the common oral capsule and tablet, as well as a topical gel. The availability of both systemic forms (oral) and a localized form (gel) provides unique versatility. This allows for treatment flexibility, enabling the active substance to be delivered either systemically via the oral route or applied locally to the affected area via the topical route.

Regulatory References

  1. Piroxicam - LiverTox - NIH

What side effects are possible with Cantor?

Official Safety Profile and Adverse Reactions

The safety profile for Cantor (Piroxicam) is categorized based on its official adverse reactions, system-organ classes, and frequency, as defined in government regulatory documents.

Serious Adverse Reactions

Regulatory agencies formally highlight severe, potentially fatal risks. These include:

  • Serious Gastrointestinal (GI) Events: The risks of GI bleeding, ulceration, and perforation are documented as serious and may occur without warning symptoms at any time during therapy.
  • Serious Cardiovascular (CV) Thrombotic Events: The potential for Myocardial Infarction and Stroke is noted, with the risk possibly increasing with longer use.
  • Serious Skin Reactions: Rare but severe cutaneous reactions, such as Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN), are explicitly documented.

Commonly Documented Adverse Effects

The most commonly listed adverse reactions (with an incidence greater than 2%) typically involve the gastrointestinal and nervous systems. These effects include nausea, constipation, flatulence, abdominal pain, diarrhea, headache, dizziness, and peripheral edema (fluid retention).

Population and Time-Related Safety Considerations

Specific safety statements are included for certain patient groups and exposure periods:

  • Older Adults: This population is officially noted to be at a significantly greater risk for serious, potentially fatal, gastrointestinal events.
  • Time-Related Patterns: The risk for cardiovascular events may manifest early in treatment, and the greatest risk for serious skin reactions is generally documented as being within the first month of treatment.
  • Other Restrictions: The medication is contraindicated in patients with a history of aspirin-sensitive asthma and should be avoided in pregnant women starting at 30 weeks gestation due to potential fetal harm.

The overall safety profile is structured to emphasize these serious risks, alongside the spectrum of more common reactions, which together define the official regulatory understanding of the medicine's safety characteristics.

Overdose and Emergency Response

Overdose and When to Seek Help

The following information is derived strictly from the official overdose sections of government-authorized regulatory documents for Cantor.

Documented Overdose Profile

Overdose scope Official Regulatory Statement
Documented Manifestations [No specific human data on signs and symptoms of acute overdose with Cantor were found in public authoritative government documents.] Official regulatory guidance requires that, where human data are unavailable, the signs, symptoms, and potential complications are based on appropriate animal or in vitro data, or experience with pharmacologically related drugs.
Serious Outcomes [Data unavailable.] Official labeling mandates documentation of complications that can occur, such as specific organ toxicity (e.g., hepatic or renal failure) or delayed effects (e.g., severe central nervous system depression, respiratory arrest).
Emergency Actions [Data unavailable.] General procedures recommended in regulatory documents for managing overdose often include supportive care, monitoring of vital signs, and specific measures such as activated charcoal or proven antidotes, where applicable. Management is typically symptomatic and supportive.
When to Seek Urgent Help Any suspected or confirmed over-ingestion of Cantor, regardless of symptoms, must be treated as a medical emergency. Contact a Poison Control Center or seek immediate emergency medical services (911/112/999) without delay to prevent potentially life-threatening outcomes.

Regulatory Context and Classification

Official regulatory documents establish the essential requirements for recognizing and managing drug overexposure. This section formally records the known clinical picture of toxicity and the management strategies, thereby defining the conditions under which immediate medical intervention is required. Prompt communication with healthcare professionals is mandated to initiate supportive measures and potentially life-saving interventions described in the prescribing information.

Therapeutic Uses of Cantor

What Cantor Treats: Main Uses and Benefits

Cantor (Piroxicam) is commonly used to help with symptomatic relief across several therapeutic domains, focusing primarily on conditions involving inflammatory or irritative processes. It is applied across domains where additional symptomatic support is needed to help maintain functional stability. The medicine is generally used to relieve symptoms related to physical discomfort, tenderness, swelling, and stiffness caused by arthritic conditions.


Therapeutic Focus

Cantor may assist with managing symptoms associated with conditions involving episodic or fluctuating manifestations, such as Rheumatoid Arthritis (RA), Osteoarthritis (OA), and acute episodes of Gouty Arthritis. It is applied in addressing symptoms that intensify over time, and provides support that helps ease the overall symptom burden related to chronic joint pain and stiffness. The medication is also relevant in clinical settings that involve acute or unstable symptom patterns, and may be part of symptomatic management for discomfort following post-traumatic states or surgical procedures.

Patients often seek this medication for conditions where symptoms may intensify temporarily, and it contributes to improved comfort during periods of heightened symptoms. “It helps address groups of symptoms that may become intense or disruptive, and assists with maintaining a sense of stability when symptoms are more noticeable.”


Quick Fact

Quick Fact: Support for Symptoms Related to Inflammatory Joint Pain and Stiffness

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Cantor is approved for use only in specific adult populations who meet all documented eligibility criteria from governmental regulatory bodies.

Populations Allowed

Use is allowed only for patients with histopathologically confirmed colorectal adenocarcinoma who have mismatch-repair-proficient/microsatellite stable (pMMR/MSS) status and measurable disease. Patients must have a good functional status, typically defined as an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1, and be confirmed to have adequate organ and bone marrow function (e.g., hepatic and renal). Use in individuals under 18 years of age is not established.

Populations Excluded or Contraindicated

Cantor is contraindicated in patients with a known history of severe allergy to any monoclonal antibody or to any component of the medication. It is also contraindicated for patients with active or prior documented severe autoimmune or inflammatory disorders or certain high-risk cardiac conditions. Use is not recommended for patients with central nervous system metastases or spinal cord compression, nor for those with a history of GI perforation or fistulae within the last six months.

Restricted Groups Eligibility Rule
Pregnancy/Lactation Prohibited/Excluded. Females of reproductive potential and males must use specified contraception during and for a period after treatment.
Organ Dysfunction Use is limited to those with adequate hepatic and renal function based on specific laboratory cut-offs.

All decisions on use must adhere strictly to these documented regulatory eligibility and exclusion criteria.

What should I know about interactions with other medicines?

The official interaction profile of Cantor is structured around specific risks and pharmacokinetic changes documented in regulatory sources. The medicine is contraindicated for the management of peri-operative pain associated with Coronary Artery Bypass Graft (CABG) surgery. Co-administration with systemic non-aspirin NSAIDs or analgesic doses of aspirin is not generally recommended due to an increased risk of serious gastrointestinal adverse events.

The profile emphasizes pharmacodynamic interactions. Co-administration with anticoagulants, SSRIs/SNRIs, and oral corticosteroids is documented to increase the risk of bleeding or gastrointestinal damage. A separate concern is interference with blood pressure control: Cantor may diminish the antihypertensive effect of ACE Inhibitors, ARBs, or Diuretics. This combination carries a risk of renal function deterioration, particularly for elderly, volume-depleted, or renally impaired patients.

The pharmacokinetic profile involves the CYP2C9 enzyme, which is the primary metabolic route, resulting in abnormally high plasma levels in individuals identified as poor metabolizers. Piroxicam can also increase the serum concentrations of co-administered Lithium and Digoxin and may reduce the clearance of Methotrexate and Pemetrexed. Finally, alcohol consumption is a documented risk factor that adds to the potential for gastrointestinal bleeding.

Mechanism of Action

Molecular Targeting of Cyclooxygenase Enzymes

The mechanism of Piroxicam (Cantor) centers on the direct, non-selective inhibition of the Cyclooxygenase (COX) enzyme system. This molecular domain involves blocking the active sites of both the constitutive COX-1 and the inducible COX-2 isoforms. The consequent reduction in the synthesis of prostaglandins—key chemical mediators that modulate inflammation and nociception—is the resulting physiological effect.

Modulation of Inflammatory and Pain Signaling Cascades

By reducing prostaglandin levels, the drug modifies several key physiological consequences that stem from tissue damage. This process dampens the local inflammatory cascade by limiting prostaglandin-mediated effects, such as vasodilation and increased vascular permeability. The mechanism also effectively inhibits the sensitization of peripheral pain receptors (nociceptors). This results in a decreased sensitization of peripheral nociceptors, which modifies signal transmission to the central nervous system.

️ Central Regulation of Elevated Body Temperature

A related physiological effect of the drug's mechanism is its influence on central thermoregulation. The inhibition of prostaglandin synthesis, specifically in the hypothalamus, modifies the thermal set-point in the hypothalamus. This acts on a signaling pathway that regulates core body temperature. This action integrates with the peripheral mechanism in the modulation of the overall inflammatory cascade.

Dosage and Administration Information

How Cantor (Piroxicam) Is Used: Administration and Official Dosing

Cantor (Piroxicam) is used based on high-level usage principles, focusing on administration route, dose limitations, and duration of use. The medicine is available for oral (capsule/tablet) administration for systemic treatment and topical (gel) administration for localized application.


Standard Labeled Regimens

The standard oral regimen for chronic conditions like Osteoarthritis and Rheumatoid Arthritis is 20 mg taken once daily (qD). This daily dose may be divided into 10 mg taken twice daily. The maximum recommended daily dose is 20 mg for chronic use. Higher initial doses, such as 40 mg daily, are reserved for the short-term treatment of acute episodes (e.g., acute gout) for only a few days before reducing to the 20 mg maintenance dose.

Indication Standard Dose Maximum Daily Dose
Chronic RA / OA 20 mg daily 20 mg
Acute Episode Initial 40 mg for 1-2 days 40 mg (initial only)

Administration Context and Time Principle

Oral Piroxicam capsules are generally instructed to be taken with or immediately after food or with a full glass of water, and must be swallowed whole. The topical gel is for external use only and is typically applied three or four times per day, being rubbed in completely to the affected area. Due to the drug's long half-life, the full systemic effect is generally not assessed until 7 to 12 days after treatment initiation. Furthermore, the protocol mandates that the need for continued chronic treatment be periodically re-evaluated to ensure the shortest effective duration of use.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Evaluating Efficacy in ADHD and Narcolepsy

The main body of research focuses on the drug's investigation in Attention-Deficit/Hyperactivity Disorder (ADHD) and narcolepsy, which are the primary indications studied.

  • The core research explored whether the drug is associated with a change in symptoms of ADHD and narcolepsy.
  • Most randomized trials reported a change in feelings of fatigue and scores on standardized cognitive function tests. These outcomes were generally measured over a 6 to 12-week trial period.
  • These trials investigated the agent's impact on specific endpoints related to these conditions.
  • Studies involving ADHD measured outcomes using behavioral rating scales completed by caregivers or teachers. For narcolepsy, the primary endpoints often included scores on the Epworth Sleepiness Scale.

Secondary Uses and Exploratory Research

Research has also looked at the potential for use in other conditions, though the evidence base remains smaller.

  • Research has explored the drug's use in off-label applications, such as investigating potential effects on chronic pain and depression. These studies typically involved smaller, open-label cohorts.
  • Preliminary studies evaluated the drug using sleep-latency measurements for excessive daytime sleepiness (EDS) in narcolepsy.

Combination Therapy Studies

A recent focus has been on combination therapy, particularly in cases where response to a single treatment has been suboptimal.

  • Studies have evaluated whether this combination therapy is associated with a statistically significant difference in endpoints compared to monotherapy alone, particularly for treatment-resistant ADHD.
  • The combination was assessed for changes in attentional capacity and impulsivity in studies with extended follow-up periods.

Reported Tolerability and Safety Findings

The reviewed trials generally employed standardized protocols to determine appropriate participant dosing for the measured effect. Studies tracked and reported the frequency and type of adverse events for most adults with these diagnoses.

Key Studies & References

  1. Modafinil - StatPearls - NCBI Bookshelf (for efficacy and adverse event rates)

Frequently Asked Questions (FAQ)

Common questions about Cantor (FAQ)

Q: What official conditions is Cantor used to address?

Official product information states that Cantor is typically used to relieve symptoms associated with chronic inflammatory conditions. This includes common conditions such as rheumatoid arthritis and osteoarthritis.


Q: Is Cantor considered a short-term or long-term treatment?

Official guidance from regulatory bodies indicates that the medication is described as being used at the lowest effective dose for the shortest duration possible. For chronic conditions, the need for continued use is subject to periodic re-evaluation by a prescriber.


Q: Can taking Cantor cause changes in sleep patterns?

Official product documentation indicates that Cantor may have effects on the nervous system. These include reported adverse reactions such as difficulty sleeping (insomnia) and drowsiness (somnolence).


Q: Is it normal to feel fatigued after starting Cantor?

Regulatory safety documents list potential effects on the Central Nervous System. Since adverse effects like dizziness and somnolence (drowsiness) are noted, these can potentially contribute to feelings of fatigue.


Q: Are there any foods or drinks that should be avoided while taking Cantor?

Official documents advise avoiding alcohol consumption while taking this medication because it can significantly increase the risk of gastrointestinal bleeding. The oral form is typically advised by official labeling to be taken with or immediately after food to help reduce irritation in the stomach.


Q: Does Cantor interact with herbal supplements or over-the-counter remedies?

Official documents primarily list interactions with other prescription drugs. While specific herbal supplements are not generally listed, official regulatory sources advise caution when combining it with over-the-counter remedies that contain compounds similar to aspirin (such as willow bark), as this could increase the chance of side effects.


Q: What should a patient expect to feel when Cantor is working?

The intended effect of the medication, based on official pharmacology, is to provide relief from symptoms caused by inflammation. This relief is typically experienced as a reduction in pain, stiffness, tenderness, and swelling.


Q: Does the effect of Cantor last for the entire day?

Official pharmacokinetic data confirms that the drug has a significantly long half-life, which is approximately 50 hours. This long duration in the body is described as supporting a typical once-daily regimen in treatment documents.


Q: What general information is available about the typical duration of a Cantor treatment course?

For chronic conditions, the full treatment course requires periodic re-evaluation by a prescriber to ensure the continued need for the medication. Treatment for acute, short-term flare-ups is often limited to a few days before reducing or stopping the medication.


Q: What are the long-term effects of taking Cantor?

Official warnings indicate that long-term use of the drug is associated with certain serious risks. These risks include an increased chance of serious cardiovascular events, such as heart attack and stroke, and serious gastrointestinal events, such as bleeding and ulceration.


Q: Is Cantor classified as a controlled substance?

Regulatory classification information indicates that the medication is not listed as a controlled substance by major drug enforcement authorities.


Q: Does Cantor have a high potential for dependence or misuse?

According to official regulatory documents, the drug is not associated with the potential for abuse or dependence. It is not classified as a controlled substance.


Q: Does taking Cantor affect a person's ability to drive or operate machinery?

Regulatory warnings state that adverse effects may occur that could impact mental and physical ability. Effects such as dizziness, somnolence (drowsiness), or visual changes may potentially impair a person’s capacity to drive or operate machinery.


Q: How is Cantor processed and eliminated by the body?

Official pharmacokinetic data describes how the body handles the drug. It is extensively metabolized (broken down) by the liver, primarily by the CYP2C9 enzyme, and is then eliminated from the body through the urine and feces.


Q: Is Cantor available over the counter or only by prescription?

The oral forms (capsules and tablets) are typically prescription-only in most regions. However, some regulatory bodies permit the sale of lower-strength topical gel formulations without a prescription in certain areas.


Q: What is the chemical name of the active compound in Cantor?

The active compound, Piroxicam, has a formal chemical name defined in official drug product documents. This name is 4-Hydroxy-2-methyl-N-(2-pyridinyl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide.


Q: How do regulatory bodies classify the safety profile of Cantor?

Regulatory bodies classify the safety profile with prominent warnings. This typically includes a Boxed Warning that highlights the significant risk of serious cardiovascular and gastrointestinal adverse events.


Q: What are the official signs of an overdose of Cantor described in regulatory information?

Signs of an overdose described in regulatory information may include convulsions, low blood pressure, severe headache, confusion, ringing in the ears, and gastrointestinal bleeding.


Q: What impact does Cantor have on laboratory test results?

The drug's official profile notes potential adverse effects on organs monitored by lab tests. This includes reports of elevated serum aminotransferase levels (which indicate liver function) and the possibility of renal dysfunction (kidney function).

How should Cantor be stored and disposed of?

How to Store and Dispose of Cantor (Piroxicam)

Official regulatory documents define strict conditions for the storage and disposal of Cantor (Piroxicam) to maintain its quality and safety.


Storage Requirements

Dosage Form Temperature & Protection Container Rule
Oral (Capsules/Tablets) Store at controlled room temperature (20°C to 25°C). Protect from moisture and light. Must be kept in a tight container.
Topical Gel Do not store above 30°C (86°F). Protect from light. Store in the original tube.

All forms of Cantor must be stored out of the sight and reach of children.


Disposal Instructions

Discard any unused or expired Cantor strictly in accordance with local and national pharmaceutical waste regulations. Medicinal products should not be disposed of via household wastewater or trash unless specifically authorized by local authorities.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Cantor found in:

A-Z Index: